Fig. 2From: Development of weight and age-based dosing of daily primaquine for radical cure of vivax malariaSimulated primaquine exposures, relative to the median exposure following administration of 30Â mg primaquine base in a 60Â kg patient (i.e. target exposure) for the developed weight-based and age-based dosing regimens. The shaded areas represent the 2.5th and 97.5th percentiles of the simulated exposuresBack to article page